|
COVID-19 (−)
|
COVID-19 (+)
|
Difference (95% CI)
|
---|
Age
| | |
80.6791***
|
< 60
|
22,850 (0.97)
|
665 (0.03)
| |
61–69
|
15,609 (0.97)
|
514 (0.03)
| |
70–79
|
17,899 (0.98)
|
418 (0.02)
| |
≥ 80
|
17,258 (0.98)
|
314 (0.02)
| |
Sex
| | |
56.6345***
|
Male
|
38,922 (0.98)
|
844 (0.02)
| |
Female
|
34,694 (0.97)
|
1067 (0.03)
| |
Diabetes Mellitus
| | |
29.5498***
|
Yes
|
30,184 (0.97)
|
902 (0.03)
| |
No
|
43,432 (0.98)
|
1009 (0.02)
| |
Cardiovascular disease
| | |
2.9933
|
Yes
|
69,012 (0.97)
|
1810 (0.03)
| |
No
|
4604 (0.98)
|
101 (0.02)
| |
Cerebrovascular disease
| | |
26.7711***
|
Yes
|
59,392 (0.97)
|
1632 (0.03)
| |
No
|
14,224 (0.98)
|
279 (0.02)
| |
Ischemic heart disease
| | |
52.4329***
|
Yes
|
61,686 (0.97)
|
1719 (0.03)
| |
No
|
11,930 (0.98)
|
192 (0.02)
| |
COPD
| | |
53.0971***
|
Yes
|
68,791 (0.97)
|
1865 (0.03)
| |
No
|
4825 (0.99)
|
46 (0.01)
| |
Malignancy
| | |
180.4433***
|
Yes
|
59,384 (0.97)
|
1775 (0.03)
| |
No
|
14,232 (0.99)
|
136 (0.01)
| |
Renal replacement therapy
| | |
74.6484***
|
Yes
|
69,301 (0.97)
|
1888 (0.03)
| |
No
|
4315 (0.99)
|
23 (0.01)
| |
ACEIs or ARBs
| | |
0.0028
|
Yes
|
12,785 (0.97)
|
331 (0.03)
| |
No
|
60,831 (0.97)
|
1580 (0.03)
| |
- * P < .05; ** P < .01; *** P < .001